Pharmstandard International S.A., 10% Owner at ARGOS THERAPEUTICS INC (ARGS), bought 33,954 shares at $4.78 ($162K) on 2016-09-01, disclosed to the SEC on 2016-09-07.
Open-market purchase of $162k ARGS by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.78 | 16,977 | $81K | 50.0% |
| 2 | $4.78 | 16,977 | $81K | 50.0% |
| Total | $4.78 avg | 33,954 | $162K | 100% |
| Filing → |
| ARGS | BUY | 2016-08-29 | $252K | — | Filing → |
| ARGS | BUY | 2016-08-25 | $305K | — | Filing → |
| ARGS | BUY | 2016-08-23 | $320K | — | Filing → |